Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma

Br J Haematol. 2003 Aug;122(4):690-1. doi: 10.1046/j.1365-2141.2003.04478.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Hemolytic, Autoimmune / drug therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / analysis
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents
  • Rituximab